Cigna (CI) is upgraded to Buy as downside risk is overdone and valuation is compelling at 9.3x 2025 earnings. CI's diversified business, strong cash flow, and proactive PBM strategy position it well despite regulatory and political headwinds. Recent PBM model changes, specialty pharmacy expansion, and robust buybacks support long-term growth and margin resilience.
Permanent Capital Management LP purchased a new position in Cigna Group (NYSE: CI) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,041 shares of the health services provider's stock, valued at approximately $877,000. Several other hedge funds
Pacer Advisors Inc. lifted its holdings in Cigna Group (NYSE: CI) by 41.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,683 shares of the health services provider's stock after purchasing an additional 9,232 shares during the quarter. Pacer
Country Club Bank grew its holdings in Cigna Group (NYSE: CI) by 18.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,464 shares of the health services provider's stock after acquiring an additional 3,135 shares during the period. Country Club
BofA Securities flagged rising cost pressures, unpredictable swing factors and heightened uncertainty around earnings estimates for managed care organizations, noting that Medicare poses greater risk than Medicaid and that reported EPS may not fully reflect underlying earnings power.
Corient Private Wealth LLC lessened its holdings in Cigna Group (NYSE: CI) by 2.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,809 shares of the health services provider's stock after selling 2,212 shares during the period.
B. Riley Wealth Advisors Inc. purchased a new stake in shares of Cigna Group (NYSE: CI) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,117 shares of the health services provider's stock, valued at approximately $1,030,000. A number of
Cigna Group (NYSE: CI - Get Free Report) was the recipient of some unusual options trading activity on Monday. Investors bought 8,461 call options on the stock. This is an increase of 109% compared to the average daily volume of 4,057 call options. Insider Buying and Selling In related news, CEO David Cordani acquired 4,134 shares
Representative Julie Johnson (D-Texas) recently sold shares of EOG Resources, Inc. (NYSE: EOG). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in EOG Resources stock on November 13th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account. Representative Julie Johnson also recently made the
Representative Julie Johnson (D-Texas) recently sold shares of PepsiCo, Inc. (NASDAQ: PEP). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in PepsiCo stock on November 13th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account. Representative Julie Johnson also recently made the following trade(s):
